NPPA Fixes Retail Prices of 37 Drug Formulations Including Atorvastatin, Ezetimibe, Telmisartan, Details Susmita Roy27 Dec 2025 10:08 PM ISTNew Delhi: Through a recent notice, the National Pharmaceutical Pricing Authority (NPPA), Ministry of Chemicals and Fertilizers, Government of India,...
Eli Lilly, Novo Nordisk race to lock in India obesity drug market Ruchika Sharma26 Dec 2025 4:23 PM ISTHyderabad: Global pharma heavyweights Eli Lilly and Novo Nordisk are racing to lock in market leadership in India’s blooming obesity drug market,...
State Drug Alert: 141 Medicine Samples Including Mankind's Telmisartan Fail CDSCO Quality Tests in November Susmita Roy23 Dec 2025 10:13 PM ISTNew Delhi: Reflecting continuing concerns over medicine quality in India's pharmaceutical supply chain, the Central Drugs Standard Control...
Cipla Secures Exclusive Rights to Sell Corex, Dolonex, Neksium, Dalacin C Under Pfizer Deal Susmita Roy20 Dec 2025 6:30 PM ISTNew Delhi: Cipla Limited has entered into a five-year exclusive supply and marketing agreement with Pfizer Products India Private Limited and Pfizer...
Indian Pharma Market Posts 9% Surge in November Even as Volumes Stay Flat: PharmaTrac Susmita Roy10 Dec 2025 5:37 PM ISTNew Delhi: The Indian Pharmaceutical Market (IPM) recorded a steady rise in November 2025, growing 9.06% month-on-month (MoM) in value, even as unit...
Cipla, Hetero win bid to supply widely prescribed diabetes drug in China Ruchika Sharma12 Nov 2025 2:27 PM ISTBeijing: In a major breakthrough for India's pharmaceutical industry, several Indian drugmakers operating in China have made some headway into...
Cohance Lifesciences appoints Rahul Pradhan as VP - Operations to head API Unit III, Ankleshwar Ruchika Sharma10 Nov 2025 4:44 PM ISTCohance Lifesciences has announced the appointment of Rahul Pradhan as Vice President - Operations to head API Unit III, Ankleshwar.A seasoned...
From Launch to Leadership: Mounjaro Crosses Rs 333 Crore, Becomes India's Top-Selling Drug Farhat Nasim8 Nov 2025 5:06 PM ISTNew Delhi: Eli Lilly's diabetes and obesity drug Mounjaro (Tirzepatide) has become India's top-selling drug by value for October 2025, overtaking...
Cipla to buy 100 percent stake in Inzpera Healthsciences for Rs 110.65 crores Ruchika Sharma3 Nov 2025 5:39 PM ISTMumbai: Cipla Limited has announced that it has entered into definitive agreements to acquire 100 percent stake in Inzpera Healthsciences...
Cipla profit up 3.7 percent at Rs 1353 crore in Q2 Ruchika Sharma2 Nov 2025 4:00 PM ISTNew Delhi: Cipla Ltd has recorded a 3.7 percent surge in Q2 consolidated net profit at Rs 1,353.37 crore. The pharma major had reported a...
Achin Gupta to succeed Umang Vohra as Cipla MD, GCEO effective April 1 Ruchika Sharma30 Oct 2025 2:36 PM ISTMumbai: Cipla Limited has announced the elevation of Achin Gupta, currently the Global Chief Operating Officer, as the company's next...
Eli Lilly's Diabetes Drug Mounjaro Gets Second Brand Yurpeak via Cipla Deal Farhat Nasim24 Oct 2025 11:36 AM ISTNew Delhi: In a move aimed at expanding access to obesity and diabetes care in India, Eli Lilly and Company (India) Pvt. Ltd. (Lilly) and Cipla...
